Published in Rev Mal Respir on May 30, 2013
[Regarding a case of rifampicin-induced pruritus and thrombocytopenia]. Rev Mal Respir (2013) 0.75
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91
Sputum induction. Eur Respir J Suppl (2002) 1.88
Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J (2002) 1.79
Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax (2009) 1.74
Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70
Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68
Iatrogenic eosinophilic pleural effusion. Eur Respir Rev (2011) 1.63
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53
Update on severe asthma: what we know and what we need. Eur Respir Rev (2009) 1.50
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Compliance in asthma. Respir Med (1999) 1.44
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
[Analysis of induced sputum in the management of asthma: a valid technique, a service rendered by community pneumonologists]. Rev Mal Respir (2002) 1.38
Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis (1992) 1.31
Asthma: a disease remodeling the airways. Allergy (1992) 1.30
Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med (1996) 1.28
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J (2003) 1.27
Neutrophils in chronic inflammatory airway diseases: can we target them and how? Eur Respir J (2010) 1.27
HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis (1993) 1.26
Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis (1992) 1.26
Are overweight asthmatics more difficult to control? Allergy (2006) 1.22
Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects. Am Rev Respir Dis (1993) 1.17
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol (1991) 1.17
Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol (1987) 1.14
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. Eur Respir J (2010) 1.08
Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Eur Respir J (2004) 1.07
Update on the roles of distal airways in COPD. Eur Respir Rev (2011) 1.07
[Factors associated with smoking in sixth grade (11-13 years old)]. Rev Mal Respir (2002) 1.07
Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med (1996) 1.05
Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol (1996) 1.05
Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med (1994) 1.03
Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma. J Allergy Clin Immunol (2001) 1.03
Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjects. J Allergy Clin Immunol (1995) 1.02
c-fos proto-oncogene expression in bronchial biopsies of asthmatics. Am J Respir Cell Mol Biol (1992) 1.01
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01
Does leptin play a cytokine-like role within the airways of COPD patients? Eur Respir J (2005) 0.99
Increased oxygen species generation in blood monocytes of asthmatic patients. Am Rev Respir Dis (1992) 0.99
5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J Exp Med (1996) 0.97
Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. J Allergy Clin Immunol (1990) 0.96
Quantification and localization of HLA-DR and intercellular adhesion molecule-1 (ICAM-1) molecules on bronchial epithelial cells of asthmatics using confocal microscopy. Clin Exp Immunol (1994) 0.96
Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J Leukoc Biol (1994) 0.96
Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am Rev Respir Dis (1993) 0.96
Structural consequences of airway inflammation in asthma. J Allergy Clin Immunol (2000) 0.95
Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J (1994) 0.95
Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages. Clin Exp Immunol (1995) 0.94
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics. Allergy (2009) 0.94
Safety and cellular assessment of bronchial brushing in airway diseases. Respir Med (1999) 0.93
Release of cytokines by blood monocytes during strenuous exercise. Int J Sports Med (1994) 0.93
Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy (2007) 0.91
Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils. Immunology (1988) 0.91
Eosinophil inflammation in asthma. Am J Respir Crit Care Med (1994) 0.90
Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochem Biophys Res Commun (2002) 0.90
Low-affinity receptor for IgE on human bronchial epithelial cells in asthma. Immunology (1994) 0.90
Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6. Allergy (2010) 0.89
Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J (2002) 0.89
Effect of theophylline and adenosine on eosinophil function. Am Rev Respir Dis (1989) 0.89
Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax (2004) 0.89
Adherence in severe asthma. Clin Exp Allergy (2012) 0.89
Expression of the high-affinity receptor for IgE on bronchial epithelial cells of asthmatics. Am J Respir Cell Mol Biol (1998) 0.89
Safety of bronchoalveolar lavage and bronchial biopsies in patients with asthma of variable severity. Am Rev Respir Dis (1992) 0.88
Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? Thorax (2004) 0.88
Beta 2-adrenergic receptors on eosinophils. Binding and functional studies. Am Rev Respir Dis (1990) 0.88
Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med (1996) 0.88
Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis. Am J Respir Cell Mol Biol (1995) 0.88
Nitrogen washout slope in poorly controlled asthma. Allergy (2006) 0.88
Safety of inducing sputum in patients with asthma of varying severity. Am J Respir Crit Care Med (1998) 0.87
5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers. Biochem Biophys Res Commun (1995) 0.86
Assessment of variations in control of asthma over time. Eur Respir J (2003) 0.86
Variable p-CREB expression depicts different asthma phenotypes. Allergy (2007) 0.86
Update on the roles of distal airways in asthma. Eur Respir Rev (2009) 0.85
Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol (1996) 0.85
Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev (2009) 0.85
Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy (2014) 0.84
Assessment of airway inflammation in asthma. Am J Respir Crit Care Med (1998) 0.84
Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy (2014) 0.83
Functional and phenotypic characteristics of bronchial epithelial cells obtained by brushing from asthmatic and normal subjects. Allergy (1993) 0.83
Role of comorbid conditions in asthma hospitalizations in the south of France. Allergy (2013) 0.83
Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur Respir Rev (2011) 0.83
Fos immunoreactivity assessment on human normal and pathological bronchial biopsies. Respir Med (1995) 0.83
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy (1996) 0.83
Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest (1992) 0.82
The role of transforming growth factor-β1 in airway inflammation of childhood asthma. Int J Immunopathol Pharmacol (2013) 0.82
How should nasal symptoms be investigated in asthma? A comparison of radiologic and endoscopic findings. Allergy (2004) 0.82
Leukotriene E4 plasma levels in adult asthmatic patients with variable disease severity. Allergy (1997) 0.82
Relation between inflammation and symptoms in asthma. Allergy (2009) 0.82